Patent - Abbreviated New Drug Application Cases filed in New Jersey
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al
as 3:2024cv04317
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: HETERO USA, INC., HETERO LABS LTD. UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
AXSOME MALTA LTD. et al v. HETERO USA INC. et al
as 2:2024cv03999
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: HETERO USA INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AXSOME MALTA LTD. et al v. HETERO USA INC. et al
as 2:2024cv00196
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: HETERO USA INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al
as 2:2023cv20354
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: ALKEM LABORATORIES LTD., AUROBINDO PHARMA USA, INC., HETERO USA INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. et al We have downloadable decisions or orders for this case
as 2:2022cv04732
Plaintiff: RIGEL PHARMACEUTICALS, INC.
Counter Claimant: ANNORA PHARMA PRIVATE LTD., HETERO LABS LTD. and HETERO USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
RIGEL PHARMACEUTICALS, INC. v. ANNORA PHARMA PRIVATE LTD. et al
as 3:2022cv04732
Plaintiff: RIGEL PHARMACEUTICALS, INC.
Defendant: ANNORA PHARMA PRIVATE LTD., HETERO LABS LTD. and HETERO USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?